The pen needles market valued at US$ 1.69 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$ 1.81 ...

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

Lilly is developing Tempo Smart Button, a device that attaches to its Tempo insulin delivery pen rang, and has said it intends to being it to market in Europe this year. A similar add-on approach ...

Third-quarter results for Medtronic (NYSE:MDT) included a timeline for a planned label expansion for its automated insulin ...

Objective: To assess the functionality and patient acceptability of HumaPen Ergo ®, a new 3.0ml reusable insulin pen. Design: Patients trialled HumaPen Ergo ® (Eli Lilly) over 5 to 7 weeks and ...

a vial was dispensed regardless of the treatment group because it was not available in a pen device at the start of the study. To prevent the delay of insulin delivery to patients on the study ...

It is designed for an automated insulin delivery system for managing directly from a smartphone. Ypsomed, during the transition period, plans to continue to manufacture pen needles as a contract ...

technology with the Medtronic automated insulin delivery (AID) and smart insulin pen systems. This collaboration is set to ...